Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Lepzacitinib

😃Good
Catalog No. T78207Cas No. 2321488-47-3
Alias ATI-1777, ATI1777

Lepzacitinib is a selective, small molecule JAK1/3 inhibitor used for the treatment of atopic dermatitis and other skin diseases. As a Janus kinase inhibitor, it reduces the inflammatory response.

Lepzacitinib

Lepzacitinib

😃Good
Purity: 99.85%
Catalog No. T78207Alias ATI-1777, ATI1777Cas No. 2321488-47-3
Lepzacitinib is a selective, small molecule JAK1/3 inhibitor used for the treatment of atopic dermatitis and other skin diseases. As a Janus kinase inhibitor, it reduces the inflammatory response.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$48In StockIn Stock
5 mg$112In StockIn Stock
10 mg$179In StockIn Stock
25 mg$378In StockIn Stock
50 mg$562In StockIn Stock
100 mg$790-In Stock
200 mg$1,120-In Stock
1 mL x 10 mM (in DMSO)$123In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Lepzacitinib is a selective, small molecule JAK1/3 inhibitor used for the treatment of atopic dermatitis and other skin diseases. As a Janus kinase inhibitor, it reduces the inflammatory response.
SynonymsATI-1777, ATI1777
Chemical Properties
Molecular Weight355.39
FormulaC18H21N5O3
Cas No.2321488-47-3
SmilesN(C1=C2C(=NC=C1C(OCC)=O)NC=C2)[C@H]3CN(C(CC#N)=O)CCC3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (225.1 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.29 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8138 mL14.0691 mL28.1381 mL140.6905 mL
5 mM0.5628 mL2.8138 mL5.6276 mL28.1381 mL
10 mM0.2814 mL1.4069 mL2.8138 mL14.0691 mL
20 mM0.1407 mL0.7035 mL1.4069 mL7.0345 mL
50 mM0.0563 mL0.2814 mL0.5628 mL2.8138 mL
100 mM0.0281 mL0.1407 mL0.2814 mL1.4069 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Lepzacitinib | purchase Lepzacitinib | Lepzacitinib cost | order Lepzacitinib | Lepzacitinib chemical structure | Lepzacitinib formula | Lepzacitinib molecular weight